Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial
Arch. bronconeumol. (Ed. impr.)
; 58(10): 689-698, Oct. 2022. ilus, tab, graf
Article
em En
| IBECS
| ID: ibc-210061
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Introduction: Iron deficiency affects exercise capacity because of the critical role iron plays in the optimal functioning of skeletal muscle metabolism. We hypothesized that intravenous iron may improve exercise tolerance, quality of life (QoL), and daily physical activity (DPA) in patients with chronic obstructive pulmonary disease (COPD). Methods: This was a placebo-controlled, single-blind, parallel-group, randomized clinical trial. Iron deficiency was defined as a ferritin level<100ng/mL or a ferritin level between 100 and 299ng/mL with a transferrin saturation<20%, with or without mild anaemia. Patients were randomized at a 2:1 ratio to receive intravenous ferric carboxymaltose or placebo. The primary objective was to investigate whether intravenous iron replacement improved endurance time from baseline by at least 33%. The secondary objectives were to evaluate impact on QoL using the COPD Assessment Test (CAT) and on DPA by accelerometry. Results: We included 66 patients, 44 (66.7%) in the intervention group and 22 (33.3%) in the placebo group. Among patients receiving ferric carboxymaltose, 23 (52.3%) achieved the primary endpoint compared to 4 (18.2%) in the placebo group [p=0.009; relative risk 3.12, (95% CI, 1.198.12)]. CAT score decreased −3 (−6.01.3) points from baseline in the intervention group (p=0.007), in contrast to placebo group [−1 (−4.02.3) points, p=0.236] with no differences in DPA and adverse events in both groups. Conclusions: Iron replacement improved exercise capacity and QoL in stable COPD patients with iron deficiency. The treatment was well tolerated. (AU)
Palavras-chave
Texto completo:
1
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
16595
/
Tolerância ao Exercício
/
Doença Pulmonar Obstrutiva Crônica
Limite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Arch. bronconeumol. (Ed. impr.)
Ano de publicação:
2022
Tipo de documento:
Article